innovation News
Most Popular innovation Story
Novartis backs out of India R&D deal
Too bad, India. Novartis CEO Daniel Vasella says he's scrapping plans to invest millions in R&D there. The reason? Intellectual property protections aren't adequate in India, Vasella says. Of... Read more...
Latest Headlines
- April 29, 2008
- December 5, 2007
- August 22, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
